Young hemodialysis patients are exposed to hyperhomocysteinemia

Journal of Renal Nutrition

Volumn 15, Issue 4, 2005, Pages 435-440

  Takenaka, Tsuneo ^a,b   Itaya, Yoshiaki ^a   Suzuki, Hiromichi ^b  

^a Shinjuku Suimei Clinic   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DRINKING BEHAVIOR; ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; RISK FACTOR;

ADULT; ALCOHOL DRINKING; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS;

EID: 26044463446     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2005.07.008     Document Type: Article

References (31)

1. M.J. Sarnak Cardiovascular complications in chronic kidney disease Am J Kidney Dis 41 suppl 5 2003 11 17
2. R. Ross Atherosclerosis N Engl J Med 340 1999 115 126
3. G.L. Bakris Angiotensin-converting enzyme inhibition to enhance vascular health Am J Hypertens 14 2001 264 269
4. M. Barenbrock, M. Hausberg, M. Kosch Effect of hyperparathyroidism on arterial distensibility in renal transplant recipients Kidney Int 54 1998 210 215
5. F. Locatelli, J.B. Cannata-Andia, T.B. Drueke Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia Nephrol Dial Transplant 17 2002 723 731
6. R. Clarke, L. Daly, K. Robinson Hyperhomocysteinemia An independent risk factor for vascular disease N Engl J Med 324 1991 1149 1155
7. R.J. Woodman, D.E. Celermajer, P.L. Thompson Folic acid does not improve endothelial function in healthy hyperhomocystenemic subjects Clin Sci 106 2004 353 358
8. R.W. Wisolar Principles of the pathogenesis of atherosclerosis E. Braunwald Heart Disease 2nd ed 1984 Saunders Philadelphia 1183 1204
9. J. Blacher, K. Demuth, A.P. Guerin Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease Artherioscler Thromb Vasc Biol 18 1998 535 541
10. J. Blacher, A.P. Guerin, B. Pannier Impact of aortic stiffness on survival in end-stage renal disease Circulation 99 1999 2434 2439
11. A.P. Guerin, J. Blacher, B. Pannier Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure Circulation 103 2001 987 992
12. T. Takenaka, K. Kobayashi, H. Suzuki Pulse wave velocity as an indicator of arteriosclerosis in hemodialysis patients Atherosclerosis 176 2004 405 409
13. A. Ichihara, M. Hayashi, M. Ryuzaki Fluvastatin prevents development of arterial stiffness in hemodialysis patients with type II diabetes mellitus Nephrol Dial Transplant 17 2002 1513 1517
14. T. Takenaka, H. Suzuki New strategy to attenuate pulse wave velocity in haemodialysis patients Nephrol Dial Transplant 20 2005 811 816
15. E. Slatopolsky, J. Finch, P. Clay A novel mechanism for skeletal resistance in uremia Kidney Int 58 2000 753 761
16. T. Takenaka, K. Takahashi, T. Kobayashi Oxidized low density lipoprotein as a marker of atherosclerosis in hemodialysis patients Clin Nephrol 58 2002 33 37
17. T. Takenaka, Y. Itaya, Y. Tsuchiya Fitness of biocompatible high-flux hemodiafiltration for dialysis-related amyloidosis Blood Purif 19 2001 10 14
18. J.M. Gonin, H. Nguyen, R. Gonin Controlled trials of very high dose folic acid, vitamin B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD J Nephrol 16 2003 522 534
19. O. Nygard, J.E. Nordrehaug, H. Refsum Plasma homocysteine levels and mortality in patients with coronary artery disease N Engl J Med 337 1997 230 236
20. C. Baigent, K. Burbury, D. Wheeler Premature cardiovascular disease in chronic renal failure Lancet 356 2000 147 152
21. H. Han, J.T. Dwyer, J. Selhub Determinants of plasma total homocysteine levels in Korean chronic renal transplant recipients J Ren Nutr 10 2000 202 207
22. M. Leblanc, V. Pichette, D. Geadah Folic acid and pyridoxal-5′- phosphate losses during high-efficiency hemodialysis in patients without hydrosoluble vitamin supplementation J Ren Nutr 10 2000 196 201
23. K. Kalantar-Zadeh, G. Block, M.H. Humphreys A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients J Am Soc Nephrol 15 2004 442 453
24. C.H. Halsted, J.A. Villanueva, A.M. Devlin Metabolic interactions of alcohol and folate J Nutr 132 suppl 8 2002 236 237
25. National High Blood Pressure Education Program Coordinating Committee The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure JAMA 289 2003 2560 2572
26. F.A. Farid, M.S. Faheem, N.M. Heshmat Study of the homocysteine status in children with chronic renal failure Am J Nephrol 24 2004 289 295
27. J. Oh, R. Wunsch, M. Turzer Advanced coronary and carotid arteriopathy in young adults with children-onset chronic renal failure Circulation 106 2002 100 105
28. J.P. Forman, E.B. Rimm, M.J. Stampfer Folate intake and the risk of incident hypertension J Am Soc Nephrol 15 2004 354A
29. E.G. Vermeulen, C.D. Stehouwer, J.W. Twisk Effect of homocysteine- lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis A randomized, placebo-controlled trial Lancet 355 2000 517 522
30. M. Righetti, G.M. Ferrario, S. Milani Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients Med Sci Monit 9 2003 19 24
31. S. Zoungas, P. Branley, P.G. Kerr Atherosclerosis and folic acid supplementation trial in chronic renal failure Baseline results Nephrology 9 2004 130 141